Turn Therapeutics Inc.

NASDAQ:TTRX

Biotechnology

Healthcare
$8.64 -2.79%

-$0.17 today

Market cap
$264.15M
Beta
2.77
P/E (TTM)
-45.0
EPS (TTM)
-$0.13
52W Low $2.57High $26.50

Volume 0.13M

Average 0.04M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$2.56M

FY 2025 · Annual

Investing Cash Flow

-$152,986.00

FY 2025 · Annual

Financing Cash Flow

$6.92M

FY 2025 · Annual

+500.4% YoY

Cash Flow Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(2.29M)(1.77M)(3.19M)
Depreciation & Amortization43.92K47.48K52.75K
Deferred Income Tax000
Stock-Based Compensation640.26K352.83K419.25K
Change in Working Capital229.74K(1.86K)2.37M
Accounts Receivables000
Inventory000
Accounts Payables002.26M
Other Working Capital229.74K(1.86K)105.03K
Other Non-Cash Items6628.65K(2.21M)
Operating Cash Flow(1.38M)(1.36M)(2.56M)
Capital Expenditures(44.31K)(99.48K)(152.99K)
Acquisitions (Net)000
Purchases of Investments000
Sales of Investments000
Other Investing Activities00(152.99K)
Investing Cash Flow(44.31K)(99.48K)(152.99K)
Debt Repayment000
Common Stock Issued500K1.15M6.92M
Common Stock Repurchased000
Dividends Paid000
Other Financing Activities000
Financing Cash Flow500K1.15M6.92M
Effect of Forex Changes000
Net Change in Cash(921.99K)(308.4K)4.2M
Free Cash Flow(1.42M)(1.46M)(2.72M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$3.2M
+ D&A$52.7K
+ Stock-Based Comp$419.2K
+ Deferred Tax$0
+ Working Capital$2.4M
- Other Non-Cash-$2.2M
= Operating Cash Flow-$2.6M
- Capex-$153.0K
= Free Cash Flow-$2.7M

Analysis

FY2025 free cash flow is -$2.7M. FCF conversion is 85.0% of net income. Operating cash flow was -$2.6M, with capex of -$153.0K. The largest bridge item is Working Capital at $2.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
S-3S-3 filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
S-3S-3 filingNov 9, 2026

Does TTRX generate free cash flow?

Turn Therapeutics Inc. (TTRX) generated -$2.72M of free cash flow in fiscal 2025.

How much operating cash flow does TTRX produce?

Operating cash flow was -$2.56M, before capital expenditures of $152,986.00.